Annual CAPEX
$585.00 K
+$314.00 K+115.87%
31 December 2023
Summary:
AIM ImmunoTech annual capital expenditures is currently $585.00 thousand, with the most recent change of +$314.00 thousand (+115.87%) on 31 December 2023. During the last 3 years, it has fallen by -$10.00 thousand (-1.68%). AIM annual CAPEX is now -90.19% below its all-time high of $5.97 million, reached on 31 December 2012.AIM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$158.00 K
-$71.00 K-31.00%
30 September 2024
Summary:
AIM ImmunoTech quarterly capital expenditures is currently $158.00 thousand, with the most recent change of -$71.00 thousand (-31.00%) on 30 September 2024. Over the past year, it has dropped by -$26.00 thousand (-14.13%). AIM quarterly CAPEX is now -90.69% below its all-time high of $1.70 million, reached on 30 September 2012.AIM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$635.00 K
-$26.00 K-3.93%
30 September 2024
Summary:
AIM ImmunoTech TTM capital expenditures is currently $635.00 thousand, with the most recent change of -$26.00 thousand (-3.93%) on 30 September 2024. Over the past year, it has increased by +$73.00 thousand (+12.99%). AIM TTM CAPEX is now -89.47% below its all-time high of $6.03 million, reached on 30 September 2012.AIM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +115.9% | -14.1% | +13.0% |
| 3 y3 years | -1.7% | +81.6% | -16.8% |
| 5 y5 years | +360.6% | +587.0% | +125.2% |
AIM CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.6% | +115.9% | -31.0% | +690.0% | -16.8% | +153.0% |
| 5 y | 5 years | -7.6% | +360.6% | -56.7% | +3850.0% | -24.9% | +153.0% |
| alltime | all time | -90.2% | +747.8% | -90.7% | +111.9% | -89.5% | +167.9% |
AIM ImmunoTech CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $158.00 K(-31.0%) | $635.00 K(-3.9%) |
| June 2024 | - | $229.00 K(+358.0%) | $661.00 K(+4.1%) |
| Mar 2024 | - | $50.00 K(-74.7%) | $635.00 K(+8.5%) |
| Dec 2023 | $585.00 K(+115.9%) | $198.00 K(+7.6%) | $585.00 K(+4.1%) |
| Sept 2023 | - | $184.00 K(-9.4%) | $562.00 K(+41.2%) |
| June 2023 | - | $203.00 K(+16.0%) | $398.00 K(+46.9%) |
| Dec 2022 | $271.00 K(-57.2%) | $175.00 K(+775.0%) | $271.00 K(+8.0%) |
| Sept 2022 | - | $20.00 K(-53.5%) | $251.00 K(-21.1%) |
| June 2022 | - | $43.00 K(+30.3%) | $318.00 K(+5.6%) |
| Mar 2022 | - | $33.00 K(-78.7%) | $301.00 K(-52.4%) |
| Dec 2021 | $633.00 K(+6.4%) | $155.00 K(+78.2%) | $633.00 K(-17.0%) |
| Sept 2021 | - | $87.00 K(+234.6%) | $763.00 K(+12.2%) |
| June 2021 | - | $26.00 K(-92.9%) | $680.00 K(-19.6%) |
| Mar 2021 | - | $365.00 K(+28.1%) | $846.00 K(+42.2%) |
| Dec 2020 | $595.00 K(+63.0%) | $285.00 K(+7025.0%) | $595.00 K(+46.9%) |
| Sept 2020 | - | $4000.00(-97.9%) | $405.00 K(-4.5%) |
| June 2020 | - | $192.00 K(+68.4%) | $424.00 K(+24.3%) |
| Mar 2020 | - | $114.00 K(+20.0%) | $341.00 K(-6.6%) |
| Dec 2019 | $365.00 K(+187.4%) | $95.00 K(+313.0%) | $365.00 K(+29.4%) |
| Sept 2019 | - | $23.00 K(-78.9%) | $282.00 K(-11.0%) |
| June 2019 | - | $109.00 K(-21.0%) | $317.00 K(+26.3%) |
| Mar 2019 | - | $138.00 K(+1050.0%) | $251.00 K(+97.6%) |
| Dec 2018 | $127.00 K(+84.1%) | $12.00 K(-79.3%) | $127.00 K(-0.8%) |
| Sept 2018 | - | $58.00 K(+34.9%) | $128.00 K(+17.4%) |
| June 2018 | - | $43.00 K(+207.1%) | $109.00 K(+58.0%) |
| Mar 2018 | - | $14.00 K(+7.7%) | $69.00 K(0.0%) |
| Dec 2017 | $69.00 K(-84.8%) | $13.00 K(-66.7%) | $69.00 K(+1.5%) |
| Sept 2017 | - | $39.00 K(+1200.0%) | $68.00 K(-34.6%) |
| June 2017 | - | $3000.00(-78.6%) | $104.00 K(-74.4%) |
| Mar 2017 | - | $14.00 K(+16.7%) | $406.00 K(-10.6%) |
| Dec 2016 | $454.00 K(-7.3%) | $12.00 K(-84.0%) | $454.00 K(-12.4%) |
| Sept 2016 | - | $75.00 K(-75.4%) | $518.00 K(+15.6%) |
| June 2016 | - | $305.00 K(+391.9%) | $448.00 K(+24.4%) |
| Mar 2016 | - | $62.00 K(-18.4%) | $360.00 K(-26.5%) |
| Dec 2015 | $490.00 K(-35.7%) | $76.00 K(+1420.0%) | $490.00 K(-18.7%) |
| Sept 2015 | - | $5000.00(-97.7%) | $603.00 K(-23.2%) |
| June 2015 | - | $217.00 K(+13.0%) | $785.00 K(-3.6%) |
| Mar 2015 | - | $192.00 K(+1.6%) | $814.00 K(+6.8%) |
| Dec 2014 | $762.00 K(-33.2%) | $189.00 K(+1.1%) | $762.00 K(-2.6%) |
| Sept 2014 | - | $187.00 K(-24.0%) | $782.00 K(-10.1%) |
| June 2014 | - | $246.00 K(+75.7%) | $870.00 K(-12.1%) |
| Mar 2014 | - | $140.00 K(-33.0%) | $990.00 K(-13.2%) |
| Dec 2013 | $1.14 M(-80.9%) | $209.00 K(-24.0%) | $1.14 M(-41.9%) |
| Sept 2013 | - | $275.00 K(-24.9%) | $1.96 M(-42.0%) |
| June 2013 | - | $366.00 K(+26.2%) | $3.39 M(-28.0%) |
| Mar 2013 | - | $290.00 K(-71.9%) | $4.70 M(-21.2%) |
| Dec 2012 | $5.97 M | $1.03 M(-39.2%) | $5.97 M(-1.0%) |
| Sept 2012 | - | $1.70 M(+0.8%) | $6.03 M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $1.68 M(+8.5%) | $4.84 M(+42.1%) |
| Mar 2012 | - | $1.55 M(+41.7%) | $3.40 M(+67.2%) |
| Dec 2011 | $2.04 M(+91.0%) | $1.09 M(+115.1%) | $2.04 M(+57.6%) |
| Sept 2011 | - | $509.00 K(+104.4%) | $1.29 M(+18.4%) |
| June 2011 | - | $249.00 K(+36.1%) | $1.09 M(+20.0%) |
| Mar 2011 | - | $183.00 K(-47.9%) | $909.00 K(-14.7%) |
| Dec 2010 | $1.07 M(+85.7%) | $351.00 K(+14.0%) | $1.07 M(+1.2%) |
| Sept 2010 | - | $308.00 K(+359.7%) | $1.05 M(+24.5%) |
| June 2010 | - | $67.00 K(-80.3%) | $846.00 K(-5.1%) |
| Mar 2010 | - | $340.00 K(+0.6%) | $891.00 K(+55.2%) |
| Dec 2009 | $574.00 K(+167.0%) | $338.00 K(+234.7%) | $574.00 K(+78.8%) |
| Sept 2009 | - | $101.00 K(-9.8%) | $321.00 K(-8.3%) |
| June 2009 | - | $112.00 K(+387.0%) | $350.00 K(+47.1%) |
| Mar 2009 | - | $23.00 K(-72.9%) | $238.00 K(+10.7%) |
| Dec 2008 | $215.00 K(-49.2%) | $85.00 K(-34.6%) | $215.00 K(-49.6%) |
| Sept 2008 | - | $130.00 K(-56.2%) | $427.00 K(+0.9%) |
| Dec 2007 | $423.00 K(-70.3%) | $297.00 K(-198.0%) | $423.00 K(+78.5%) |
| Sept 2007 | - | -$303.00 K(-184.4%) | $237.00 K(-59.4%) |
| June 2007 | - | $359.00 K(+412.9%) | $584.00 K(-3.6%) |
| Mar 2007 | - | $70.00 K(-36.9%) | $606.00 K(-57.4%) |
| Dec 2006 | $1.42 M(+21.7%) | $111.00 K(+152.3%) | $1.42 M(-31.8%) |
| Sept 2006 | - | $44.00 K(-88.5%) | $2.09 M(-7.6%) |
| June 2006 | - | $381.00 K(-57.1%) | $2.26 M(+13.5%) |
| Mar 2006 | - | $888.00 K(+14.7%) | $1.99 M(+70.0%) |
| Dec 2005 | $1.17 M(+226.8%) | $774.00 K(+260.0%) | $1.17 M(-225.1%) |
| Sept 2005 | - | $215.00 K(+92.0%) | -$935.00 K(-336.1%) |
| June 2005 | - | $112.00 K(+62.3%) | $396.00 K(+39.4%) |
| Mar 2005 | - | $69.00 K(-105.2%) | $284.00 K(-20.7%) |
| Dec 2004 | $358.00 K(+106.9%) | -$1.33 M(-186.1%) | $358.00 K(-80.6%) |
| Sept 2004 | - | $1.55 M(>+9900.0%) | $1.84 M(+520.5%) |
| June 2004 | - | $0.00(-100.0%) | $297.00 K(-6.0%) |
| Mar 2004 | - | $143.00 K(-7.1%) | $316.00 K(+82.7%) |
| Dec 2003 | $173.00 K(+1.2%) | $154.00 K(>+9900.0%) | $173.00 K(-239.5%) |
| Sept 2003 | - | $0.00(-100.0%) | -$124.00 K(-752.6%) |
| June 2003 | - | $19.00 K(-113.3%) | $19.00 K(>+9900.0%) |
| Dec 2002 | - | -$143.00 K(-200.0%) | $0.00(-100.0%) |
| Sept 2002 | - | $143.00 K(+133.3%) | $143.00 K(-16.4%) |
| Dec 2000 | $171.00 K(-31.9%) | $61.30 K(-752.1%) | $171.00 K(+6.4%) |
| Sept 2000 | - | -$9400.00(-116.5%) | $160.70 K(-5.5%) |
| June 2000 | - | $57.10 K(-7.9%) | $170.10 K(-20.1%) |
| Mar 2000 | - | $62.00 K(+21.6%) | $213.00 K(-15.1%) |
| Dec 1999 | $251.00 K(+25.5%) | $51.00 K(>+9900.0%) | $251.00 K(-16.3%) |
| Sept 1999 | - | $0.00(-100.0%) | $300.00 K(-25.0%) |
| June 1999 | - | $100.00 K(0.0%) | $400.00 K(+33.3%) |
| Mar 1999 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Dec 1998 | $200.00 K(+100.0%) | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Sept 1998 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
| Dec 1996 | $100.00 K | $0.00(-100.0%) | $100.00 K(0.0%) |
| Sept 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is AIM ImmunoTech annual capital expenditures?
- What is the all time high annual CAPEX for AIM ImmunoTech?
- What is AIM ImmunoTech annual CAPEX year-on-year change?
- What is AIM ImmunoTech quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly CAPEX year-on-year change?
- What is AIM ImmunoTech TTM capital expenditures?
- What is the all time high TTM CAPEX for AIM ImmunoTech?
- What is AIM ImmunoTech TTM CAPEX year-on-year change?
What is AIM ImmunoTech annual capital expenditures?
The current annual CAPEX of AIM is $585.00 K
What is the all time high annual CAPEX for AIM ImmunoTech?
AIM ImmunoTech all-time high annual capital expenditures is $5.97 M
What is AIM ImmunoTech annual CAPEX year-on-year change?
Over the past year, AIM annual capital expenditures has changed by +$314.00 K (+115.87%)
What is AIM ImmunoTech quarterly capital expenditures?
The current quarterly CAPEX of AIM is $158.00 K
What is the all time high quarterly CAPEX for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly capital expenditures is $1.70 M
What is AIM ImmunoTech quarterly CAPEX year-on-year change?
Over the past year, AIM quarterly capital expenditures has changed by -$26.00 K (-14.13%)
What is AIM ImmunoTech TTM capital expenditures?
The current TTM CAPEX of AIM is $635.00 K
What is the all time high TTM CAPEX for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM capital expenditures is $6.03 M
What is AIM ImmunoTech TTM CAPEX year-on-year change?
Over the past year, AIM TTM capital expenditures has changed by +$73.00 K (+12.99%)